LENZ THERAPEUTICS, INC. Public Float
LENZ THERAPEUTICS, INC. (LENZ) had Public Float of $690.10 million as of 2025-06-30, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-24
- 2025-06-30: Entity Public Float $690.10M.
- 2024-06-28: Entity Public Float $362.60M.
- 2023-06-30: Entity Public Float $150.80M.
- 2022-12-30: Entity Public Float $66.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $690.10M 10-K · filed 2026-03-24 |
| 2024-06-28 | $362.60M 10-K · filed 2025-03-19 |
| 2023-06-30 | $150.80M 10-K · filed 2024-02-27 |
| 2022-12-30 | $66.10M 10-K/A · filed 2023-04-27 |
| 2022-06-30 | $150.10M 10-K · filed 2023-03-20 |
| 2021-06-30 | $817.40M 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |